FDA approves Crestor’s generic rivals, much to Astrazeneca’s dismay The Food and Drug Administration on Wednesday approved several generic versions of the popular cholesterol-lowering drug Crestor, ...

The cholesterol drug Crestor is being relabeled to add a caution that starter doses should be reduced in Asian-Americans and some other patients. The Food and Drug Administration said Wednesday that ...

London, UK, 25 October 2004. New data presented today from several studies involving more than 5,000 patients provide further evidence of the outstanding efficacy of CRESTOR TM (rosuvastatin) in ...

DALLAS -- Contrary to government claims, side effects happen more often with Crestor, a cholesterol-lowering drug that consumer advocates tried to get off the market earlier this year, a new analysis ...

NEW ORLEANS (Reuters) - AstraZeneca Plc's cholesterol drug Crestor significantly slowed build-up of plaque in the main artery supplying blood to the brain compared with a placebo in a two-year study ...

The Food and Drug Administration is seeking to block an ad touting the safety of the cholesterol drug Crestor, calling the claims misleading. The agency asked the drug maker, AstraZeneca, to ...

WASHINGTON (Reuters) - U.S. regulators see benefits to using an AstraZeneca Plc cholesterol drug in a vast new group of patients but will ask outside advisers to probe various safety issues, documents ...

The first blood test to help diagnose Alzheimer disease is now for sale; AstraZeneca will sell the rights to its cholesterol drug Crestor for $320 million; Black children are disproportionately ...

With the government's blessing, a drug giant is about to expand the market for its blockbuster cholesterol medication Crestor to a new category of customers: as a preventive measure for millions of ...

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has agreed to sell the rights to Crestor ( rosuvastatin) and associated medicines in over 30 countries in Europe, except the UK and ...